Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.
|Latest Investor Presentation
(Updated May 13, 2021)
|Latest Earnings Presentation
(Updated May 10, 2021)
Data Provided by Refinitiv. Minimum 15 minutes delayed.